Zimmer Biomet Holdings (ZBH) Share-based Compensation (2009 - 2026)

Zimmer Biomet Holdings has reported Share-based Compensation for 18 years, with the latest figure at $23.8 million in Q2 2026.

• On a quarterly basis, Share-based Compensation rose 9.17% year-over-year to $23.8 million in Q2 2026; TTM through Jun 2026 was $118.5 million, a 11.79% increase from a year earlier, with the FY2025 full-year figure at $113.3 million, down 33.9% from the prior year.
• Share-based Compensation was $23.8 million for Q2 2026 at Zimmer Biomet Holdings, down from $24.2 million in the prior quarter.
• The five-year high for Share-based Compensation was $79.2 million in Q1 2024, with the low at $20.6 million in Q4 2024.
• Average Share-based Compensation over 5 years is $39.9 million, with a median of $38.0 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2025: Share-based Compensation jumped 106.6% in 2022, then slumped 73.48% in 2025.
• Over 5 years, Share-based Compensation stood at $40.7 million in 2022, then gained by 9.34% to $44.5 million in 2023, then slumped by 53.71% to $20.6 million in 2024, then advanced by 12.14% to $23.1 million in 2025, then climbed by 3.03% to $23.8 million in 2026.
• The last three Share-based Compensation figures came in at $23.8 million (Q2 2026), $24.2 million (Q1 2026), and $23.1 million (Q4 2025), per Business Quant data.